<div id="readability-page-1"><p>Synopsys (NASDAQ:SNPS - Get Free Report) is projected to release its  Q4 2025 results after the market closes on Wednesday, December 10th. Analysts expect the company to announce earnings of $2.79 per share and revenue of $2.2497 billion for the quarter. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. Individuals are encouraged to explore the company's upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, December 10, 2025 at 5:00 PM ET.</p><ul><li>NVIDIA’s $2B Power Play: Securing the Future of Chip Design</li></ul><p>Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.77 billion. During the same period last year, the business posted $3.43 earnings per share. The company's quarterly revenue was up 14.0% compared to the same quarter last year.  On average, analysts expect Synopsys to post $11 EPS for the current fiscal year and $13 EPS for the next fiscal year. </p><h2>Synopsys Price Performance</h2><p>Shares of Synopsys stock opened at $449.35 on Wednesday. The business's fifty day moving average price is $437.96 and its 200 day moving average price is $506.34. Synopsys has a twelve month low of $365.74 and a twelve month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $83.47 billion, a P/E ratio of 35.27, a PEG ratio of 5.02 and a beta of 1.16. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>MarketBeat Week in Review – 09/15 - 09/19</li></ul><p>Several research firms have recently weighed in on SNPS. Needham &amp; Company LLC reduced their price objective on Synopsys from $660.00 to $550.00 and set a &#34;buy&#34; rating on the stock in a research note on Wednesday, September 10th. Morgan Stanley decreased their price objective on shares of Synopsys from $715.00 to $510.00 and set an &#34;overweight&#34; rating for the company in a research note on Thursday, September 11th. Zacks Research upgraded Synopsys from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Monday, November 10th. Rosenblatt Securities  reaffirmed a &#34;neutral&#34; rating and set a $605.00 price target (down previously from $650.00) on shares of Synopsys in a research note on Wednesday, September 10th. Finally, BNP Paribas started coverage on Synopsys in a research report on Thursday, October 2nd. They issued an &#34;underperform&#34; rating and a $425.00 target price on the stock. Ten analysts have rated the stock with a Buy rating, six have assigned  a Hold rating and two have assigned  a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of &#34;Hold&#34; and an average price target of $556.33.</p><p><b>View Our Latest Stock Report on SNPS</b></p><h2>Insider Activity</h2><ul><li>Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall</li></ul><p>In other news, CFO Shelagh Glaser sold 3,655 shares of the firm's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This trade represents a 19.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, Director Robert G. Painter acquired 350 shares of the business's stock in a transaction that occurred on Thursday, September 11th. The stock was bought at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the purchase, the director owned 2,291 shares of the company's stock, valued at $974,683.04. This trade represents a 18.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders sold 19,528 shares of company stock valued at $10,066,095. Company insiders own  0.62% of the company's stock. </p><h2>Institutional Investors Weigh In On Synopsys</h2><p>Institutional investors have recently modified their holdings of the company. Brighton Jones LLC boosted its position in  Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares during the last quarter.  Integrated Wealth Concepts LLC lifted its stake in shares of  Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock valued at $326,000 after purchasing an additional 79 shares during the period.  NewEdge Advisors LLC boosted its position in shares of  Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock valued at $1,291,000 after purchasing an additional 395 shares in the last quarter.  WINTON GROUP Ltd boosted its position in shares of  Synopsys by 9.2% during the 2nd quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock valued at $389,000 after purchasing an additional 64 shares in the last quarter.  Finally, Treasurer of the State of North Carolina grew its stake in  Synopsys by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company's stock worth $36,962,000 after purchasing an additional 1,505 shares during the period. 85.47% of the stock is owned by institutional investors. </p><h2>Synopsys Company Profile</h2> (Get Free Report)<p>Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.</p><h2>See Also</h2><ul><li>Five stocks we like better than Synopsys</li><li>ESG Stocks, What Investors Should Know</li><li>Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?</li><li>How to Use High Beta Stocks to Maximize Your Investing Profits</li><li>Checkmate in the Cloud: ServiceNow's Shopping Spree</li><li>Stock Average Calculator      </li><li>The Contrarian Case for MSTR Amid MSCI Delisting Debacle</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Synopsys Right Now?</h2><p>Before you consider Synopsys, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.</p><p>While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SNPS

<p>Synopsys (NASDAQ:SNPS) will release its Q4 2025 earnings after market close on December 10. Analysts expect earnings of $2.79 per share and revenue of $2.2497 billion. The company has set its FY 2025 guidance at 12.760-12.800 EPS. Recent earnings missed estimates, reporting $2.30 EPS. Analysts have mixed ratings on the stock, with a consensus rating of 'Hold' and an average price target of $556.33. Insider trading activity includes significant stock sales and purchases.</p>

Synopsys (SNPS) to Release Quarterly Earnings on Wednesday